PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Macure Pharma ApS
MP

Macure Pharma ApS

UK public-sector supplier
SME

Macure Pharma ApS is an international, privately owned specialty pharmaceutical company focused on niche pharmaceuticals across various therapeutic areas. They have a commercial presence in over 25 countries worldwide.

macurepharma.com ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£407.5m
Live
12
Buyers
4
12m
£403.7m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities1
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts12 / 16
  • Top buyers4
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Macure Pharma ApSUpdated 06 Jul 2026

At a glance · for buyers and watchdogs

Macure Pharma ApS has won £407.5m across 4 public-sector buyers, with 12 live contracts.

Why: top buyer NHS England at 100% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
No CH recordCompany status
12 of 16Live contracts
100%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Services · 1
Pharmaceutical ProductsMacure provides safe, reliable pharmaceutical products ensuring quality and patient well-being. ↗
Frameworks & DPS · 1 from notices
  • NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement · £944k

Extracted automatically from macurepharma.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships · 2

Credentials listed on the supplier’s website. Not yet checked against issuer registers.

◐ From supplier website
Core credentials · 0/6
Cyber EssentialsNot evidenced✓
Cyber Essentials PlusNot evidenced✓
ISO 27001 — Information securityNot evidenced✓
ISO 9001 — QualityNot evidenced✓
ISO 14001 — EnvironmentalNot evidenced✓
ISO 45001 — Health & safetyNot evidenced✓
Other credentials & memberships · 2
Wholesale Distribution AuthorizationsRegulatory
Manufacturing and Importation AuthorizationRegulatory

Extracted automatically from macurepharma.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 12 live · 4 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS National Generic Pharmaceuticals - Wave 15c
NHS England—01 Jun 2026£403.7m2 yrspending
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2)
NHS England3360000001 Jun 2024£0.023 yrsLive
NHS National Generic Pharmaceuticals Wave 14a
NHS England3360000001 Feb 2023£2.1m2 yrsClosed
NHS National Pharmaceuticals Transition 2022_1
NHS England and NHS Improvement3360000029 Jul 2022£944k1.8 yrsClosed
NHS National Pharmaceuticals Transition 2021_3
NHS England3360000001 Oct 2021£722k2.7 yrsClosed
NP35925 Cardiovascular & Respiratory Medicines
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)33600000———Live
NHS National Pharmaceuticals Transition 2021_3
The NHS Commissioning Board (operating under the name of NHS England)33600000———Live
NHS National Generic Pharmaceuticals Wave 15b
NHS England33600000———Live
NHS National Generic Pharmaceuticals Wave 14c
NHS England33600000———Live
NHS National Generic Pharmaceuticals Wave 14b
NHS England33600000———Live
Total live value £0.02 · mean award £25.5m1–10 of 16

Top buyers · 4 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
11 contracts
100%
since 2021
2
NHS England and NHS Improvement
1 contract
0%
since 2022
3
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
2 contracts
0%
4
The NHS Commissioning Board (operating under the name of NHS England)
2 contracts
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire12 contracts
100%
Scotland2 contracts
0%
North West2 contracts
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Macure Pharma ApS highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
MP
Macure Pharma ApS
Yes£403.7m—
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m22
JA
Janssen-Cilag Ltd
Yes£117.6m18
AB
AbbVie Ltd
Yes£95.2m12
TA
Thornton and Ross Ltd
Yes£72.5m12
AC
ACCORD-UK LTD
Yes£71.2m21
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
No Companies House record linked — automated risk checks unavailable.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
No Companies House record linked — statutory compliance checks unavailable.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Registered details, directors and PSC.

✓ Live sync
🏛

No Companies House record linked

No Companies House number on file — this supplier may be overseas, a sole trader or a consortium.

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
—
— · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.